Acquifer chief operating officer: 'We anticipate the ability to greatly expand the reach of our scientific computing and imaging technologies'

Technology
Cdc cyhgwd1i fa unsplash
Acquifer Imaging GmbH is expected to edify Bruker’s catalog of advanced fluorescence microscopy imaging products. | Unsplash/CDC

Bruker Corporation, based in Billerica, Massachusetts, recently acquired big-data management solutions provider, Acquifer Imaging GmbH, according to a press release.

“Cutting-edge bioresearch often requires high-performance big-data management, which HIVE can offer,” said Dr. Peter Zehetmayer, COO and director for sales and marketing at Acquifer. “In addition, our IM04 system expands Bruker’s fluorescence microscopy portfolio into the high-content screening arena. As part of Bruker, we anticipate the ability to greatly expand the reach of our scientific computing and imaging technologies worldwide.”

Acquifer Imaging GmbH is expected to edify Bruker’s catalog of advanced fluorescence microscopy imaging products, which includes light-sheet and super-resolution microscopy products intended to generate data.

Specializing in bioimaging and high-content microscopy, the company offers high data collection speed and multicore, multi-GPU processing, as well as scalable plug-and-play storage modules capable of reaching a petabyte (PB) range. 

The acquisition will also include an “IM04 Imaging Instrument, a robust, automated high-content imaging system for reproducible phenotypic screening of cells, whole organisms and organoids,” a recent press release reveals.

“The Acquifer HIVE system was developed to keep up with the ever-increasing amount of data that life science research can generate. In combination with Bruker’s fluorescence microscopy platforms, including our light-sheet microscopy instrumentation, we can now offer a holistic solution for advanced imaging and big-data management,” said Dr. Malte Wachsmuth, managing director and head of applications, support and service for Bruker’s Luxendo Light Sheet Microscopy Business. “We also are very excited about augmenting our support for organoid, stem cell and developmental biology research with the IM04 high-content screening system.”